BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26887955)

  • 1. Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L.
    Rogers KD; Pilling M; Davies L; Belk R; Nassimi-Green C; Young A
    Qual Life Res; 2016 Jul; 25(7):1825-34. PubMed ID: 26887955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validation of the Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS) with deaf British sign language users in the UK.
    Rogers KD; Dodds C; Campbell M; Young A
    Health Qual Life Outcomes; 2018 Jul; 16(1):145. PubMed ID: 30041627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health State Values of Deaf British Sign Language (BSL) Users in the UK: An Application of the BSL Version of the EQ-5D-5L.
    Shields GE; Rogers KD; Young A; Dedotsi S; Davies LM
    Appl Health Econ Health Policy; 2020 Aug; 18(4):547-556. PubMed ID: 31942693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
    Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
    Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
    Pattanaphesaj J; Thavorncharoensap M
    Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British Sign Language versions of the Patient Health Questionnaire, the Generalized Anxiety Disorder 7-item Scale, and the Work and Social Adjustment Scale.
    Rogers KD; Young A; Lovell K; Campbell M; Scott PR; Kendal S
    J Deaf Stud Deaf Educ; 2013 Jan; 18(1):110-22. PubMed ID: 23197315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation, Cross-Cultural Adaptation, and Psychometric Testing of Yoruba Version of the EQ-5D Questionnaire in Patients With Musculoskeletal Disorders.
    Fatoye F; Akinfala AE; Gebrye T; Fatoye C; Ojelade TF; Oyewole OO; Mbada CE
    Front Public Health; 2022; 10():902680. PubMed ID: 35832283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reliability of British Sign Language and English versions of the Clinical Outcomes in Routine Evaluation--Outcome Measure with d/Deaf populations in the UK: an initial study.
    Rogers K; Evans C; Campbell M; Young A; Lovell K
    Health Soc Care Community; 2014 May; 22(3):278-89. PubMed ID: 24206212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.
    Xie S; Wang D; Wu J; Liu C; Jiang W
    Health Qual Life Outcomes; 2022 Jun; 20(1):96. PubMed ID: 35710429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.
    Sakthong P; Munpan W
    Appl Health Econ Health Policy; 2017 Oct; 15(5):669-679. PubMed ID: 28290106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
    Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.
    Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM
    Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
    Kangwanrattanakul K; Parmontree P
    Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the EQ-5D-5L questionnaire among the general population of Poland.
    Młyńczak K; Golicki D
    Qual Life Res; 2021 Mar; 30(3):817-829. PubMed ID: 33099710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population.
    Kangwanrattanakul K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):765-774. PubMed ID: 32981380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
    Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
    J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.